Qurient Co. Ltd (115180) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.374x

Based on the latest financial reports, Qurient Co. Ltd (115180) has a cash flow conversion efficiency ratio of -0.374x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-8.15 Billion ≈ $-5.52 Million USD) by net assets (₩21.80 Billion ≈ $14.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Qurient Co. Ltd for the company's overall valuation and market capitalisation.

Qurient Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Qurient Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Qurient Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qurient Co. Ltd ranked by their cash flow conversion efficiency. See 115180 debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Churchill Capital Corp XI NASDAQ:CCXI	-0.001x
First Sensor AG F:SIS	0.034x
Atos SE PA:ATO	-0.308x
Jamna Auto Industries Limited NSE:JAMNAAUTO	0.273x
Shenzhen Sunyes Electronic Manufacturing Holding Co Ltd SHE:002388	-0.066x
Queen's Road Capital Investment Ltd. TO:QRC	0.002x
S&S TECH Corporation KQ:101490	0.039x
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd SHE:300384	-0.003x

Annual Cash Flow Conversion Efficiency for Qurient Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Qurient Co. Ltd from 2014 to 2025. View Qurient Co. Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩39.19 Billion ≈ $26.56 Million	₩-28.67 Billion ≈ $-19.43 Million	-0.732x	-80.73%
2024-12-31	₩57.60 Billion ≈ $39.03 Million	₩-23.32 Billion ≈ $-15.80 Million	-0.405x	+14.10%
2023-12-31	₩46.62 Billion ≈ $31.59 Million	₩-21.97 Billion ≈ $-14.89 Million	-0.471x	+33.78%
2022-12-31	₩35.14 Billion ≈ $23.81 Million	₩-25.00 Billion ≈ $-16.94 Million	-0.712x	-57.89%
2021-12-31	₩54.08 Billion ≈ $36.65 Million	₩-24.37 Billion ≈ $-16.52 Million	-0.451x	-28.45%
2020-12-31	₩56.57 Billion ≈ $38.33 Million	₩-19.85 Billion ≈ $-13.45 Million	-0.351x	+74.59%
2019-12-31	₩17.38 Billion ≈ $11.78 Million	₩-24.00 Billion ≈ $-16.26 Million	-1.381x	-294.23%
2018-12-31	₩39.41 Billion ≈ $26.70 Million	₩-13.80 Billion ≈ $-9.36 Million	-0.350x	+59.55%
2017-12-31	₩14.53 Billion ≈ $9.85 Million	₩-12.59 Billion ≈ $-8.53 Million	-0.866x	-113.10%
2016-12-31	₩24.35 Billion ≈ $16.50 Million	₩-9.90 Billion ≈ $-6.71 Million	-0.406x	+84.40%
2015-12-31	₩2.89 Billion ≈ $1.96 Million	₩-7.54 Billion ≈ $-5.11 Million	-2.605x	-950.52%
2014-12-31	₩-21.68 Billion ≈ $-14.69 Million	₩-6.64 Billion ≈ $-4.50 Million	0.306x	--

About Qurient Co. Ltd

KQ:115180 Korea Biotechnology

Market Cap

$540.41 Million

₩797.43 Billion KRW

Market Cap Rank

#11947 Global

#324 in Korea

Share Price

₩21400.00

Change (1 day)

-4.46%

52-Week Range

₩14320.00 - ₩50900.00

All Time High

₩50900.00